Sen. Ricketts Introduces Bill to Sanction Chinese Entities Over Potent Nitazene Opioid Trafficking
This bill is currently in the early stages of the legislative process. It was recently introduced and sent to the Senate Committee on Banking, Housing, and Urban Affairs for review. There are no upcoming votes scheduled at this time.
While there is strong bipartisan support for fighting the opioid crisis, this specific bill is currently led by one party and must compete with other similar proposals in committee.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
U.S. businesses that import chemicals or other goods from Chinese companies could face disruptions if their suppliers are designated as foreign opioid traffickers. While the bill targets entities involved in drug trafficking, the broad sanctions authority could create compliance burdens for importers dealing with Chinese chemical manufacturers more generally.
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Sen. David McCormick introduced a bill to increase sanctions on Chinese entities supporting nitazene manufacturing. The legislation aims to prevent nitazenes from becoming the next fentanyl crisis by targeting the financial systems of those producing the synthetic opioids.
Bipartisan lawmakers introduced the Nitazene Sanctions Act to levy sanctions on Chinese persons and entities involved in the production of nitazenes. The bill targets the flow of precursor chemicals from China to Mexican cartels, aiming to freeze assets of those facilitating the trade.

A new bipartisan effort targets nitazenes, which are produced in China and moved through Mexican cartels. The legislation includes sanctions and tariffs to force foreign governments to act against illicit drug producers as authorities warn they are 'behind the curve' on these synthetic shifts.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Nitazene Sanctions Act
Analysis generated by AI. Always verify with official sources.